Industry: IoT
Competition
European Startup Prize for Mobility 2026: Bewerbungsphase gestartet
Noch bis 13. Juni 2026 läuft die Bewerbungsfrist für die 7. Runde des European Startup Prize for Mobility (EUSP). Das…
Competition
Innovis VC: Einstieg ins Venture Capital
Innovis VC bietet Studierenden den Einstieg in die VC-Welt. Sammelt Praxiserfahrung, baut euer Netzwerk aus und startet eure Karriere im…
ecosystem
“We can’t predict success at the beginning” – SCE CEO Klaus Sailer on flawed startup logic
Many startups are written off early – but according to Klaus Sailer in the Pitch & People videocast, that's often where the greatest potential lies…
Deals
LfA funding almost doubled in 2025
LfA Förderbank Bayern increased its total funding output in 2025 by 45 percent compared to the previous year, reaching €2.67 billion.
Deals
Munich-based clean energy startup Spine receives 3 million euros
Munich-based startup Spine has raised €3 million in its second funding round. According to the company, the new funds will be used for…
Deals
Openlaw secures €2.8 million for notarial platform Beglaubigt.de
Openlaw, with its brand Beglaubigt.de, is driving the digitalization of notary processes and attracting international investors. The platform aims to drastically reduce the number of startups…
7 Questions
Wingmaite: Fighting Corporate Dementia
Wingmaite safeguards knowledge that would otherwise be lost: The Munich-based startup makes implicit experiential knowledge usable for employees and AI. Founder…
ecosystem
Munich Startup Recap 16/26
Peak Quantum celebrates a successful pre-seed round, Munich-based Contech startup Conxai secures new millions, and Vyoma CEO Stefan Frey...
Competition
Apply now for the Life Science Pitch Day!
The Life Science Pitch Day, organized by High-Tech Gründerfonds (HTGF) and the Innovation and…, will take place in Munich on July 2, 2026.
Deals
130 million deal: Munich-based laser startup Mynaric becomes part of Rocket Lab
Rocket Lab has completed its acquisition of Munich-based Mynaric AG for a total of approximately €131 million ($155 million)...
7 Questions
Rnatics: Hope for pulmonary fibrosis
Rnatics is developing RCS-21, a novel inhalable drug for pneumonia and idiopathic pulmonary fibrosis. The startup was founded in 2021 as a spin-off of…
Inside Stories
Munich universities produce the most exit entrepreneurs.
A recent analysis shows that hardly any other location produces as many successful startup founders as Munich. At the same time, there is a need to catch up in terms of…
